GENE ONLINE|News &
Opinion
Blog

2018-05-17|

May 17, 2013: Dr. Janet Rowley Received Albany Medical Center Prize in Medicine and Biomedical Research

by GeneOnline
Share To

On May 17, 2013, American geneticist Janet Rowley was awarded the Albany Medical Center Prize in Medicine and Biomedical Research which was an important indicator of being regarded for the Nobel Prize. Rowley’s award-winning study shown that chronic myeloid leukemia cells have abnormal recombination on it chromosome 22, which in turn produces Bcr-Abl mutant kinases. This study was the foundation of developing the first drug (Imatinib) for targeted therapy in the world.

Reference
http://articles.chicagotribune.com/2013-04-17/news/ct-met-janet-rowley-prize-20130417_1_albany-medical-center-prize-leukemia-gleevec

Image Source
https://www.timesunion.com/local/article/Lowering-the-cost-of-saving-lives-4527098.php#photo-4645736

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Fifth HIV Patient Cured After Stem Cell Transplant in Germany
2023-03-01
R&D
First Sustainable Chromosome Changes in Mammals
2022-09-01
R&D
Are iPSCs safe? Nearly 75% of Skin Stem Cells Have Severe DNA Damage from UV Exposure
2022-08-29
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top